News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
314,194 Results
Type
Article (13398)
Company Profile (19)
Press Release (300777)
Multimedia
Podcasts (12)
Webinars (4)
Section
Business (97597)
Career Advice (657)
Deals (17089)
Drug Delivery (36)
Drug Development (36380)
Employer Resources (58)
FDA (6237)
Job Trends (6011)
News (158359)
Policy (12050)
Tag
Academia (1005)
Accelerated approval (2)
Adcomms (6)
Allergies (31)
Alliances (18610)
ALS (32)
Alzheimer's disease (470)
Antibody-drug conjugate (ADC) (37)
Approvals (6254)
Artificial intelligence (68)
Autoimmune disease (9)
Automation (6)
Bankruptcy (114)
Best Places to Work (4820)
BIOSECURE Act (9)
Biosimilars (17)
Biotechnology (21)
Bladder cancer (48)
Brain cancer (13)
Breast cancer (98)
Cancer (993)
Cardiovascular disease (79)
Career advice (572)
Career pathing (6)
CAR-T (66)
Cell therapy (182)
Cervical cancer (7)
Clinical research (29987)
Collaboration (244)
Compensation (175)
Complete response letters (5)
COVID-19 (752)
CRISPR (19)
C-suite (120)
Cystic fibrosis (30)
Data (1091)
Decentralized trials (2)
Depression (13)
Diabetes (102)
Diagnostics (3067)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (22)
Drug discovery (30)
Drug pricing (41)
Drug shortages (5)
Duchenne muscular dystrophy (20)
Earnings (45152)
Editorial (14)
Employer branding (7)
Employer resources (54)
Events (56330)
Executive appointments (372)
FDA (6673)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (255)
Gene editing (41)
Generative AI (3)
Gene therapy (113)
GLP-1 (228)
Government (1367)
Grass and pollen (2)
Guidances (24)
Healthcare (8801)
Huntington's disease (2)
IgA nephropathy (15)
Immunology and inflammation (29)
Indications (13)
Infectious disease (789)
Inflammatory bowel disease (49)
Inflation Reduction Act (6)
Influenza (15)
Intellectual property (26)
Interviews (72)
IPO (8796)
IRA (16)
Job creations (1340)
Job search strategy (525)
Kidney cancer (10)
Labor market (7)
Layoffs (129)
Leadership (7)
Legal (3059)
Liver cancer (27)
Lung cancer (130)
Lymphoma (80)
Machine learning (2)
Management (21)
Manufacturing (85)
MASH (44)
Medical device (5754)
Medtech (5756)
Mergers & acquisitions (8547)
Metabolic disorders (244)
Multiple sclerosis (13)
NASH (7)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (631)
NextGen: Class of 2025 (2844)
Non-profit (2295)
Now hiring (3)
Obesity (105)
Opinion (66)
Ovarian cancer (26)
Pain (32)
Pancreatic cancer (43)
Parkinson's disease (50)
Partnered (6)
Patents (41)
Patient recruitment (53)
Peanut (17)
People (30490)
Pharmaceutical (6)
Pharmacy benefit managers (8)
Phase I (8837)
Phase II (12691)
Phase III (10446)
Pipeline (683)
Policy (61)
Postmarket research (1475)
Preclinical (4087)
Press Release (67)
Prostate cancer (59)
Psychedelics (5)
Radiopharmaceuticals (127)
Rare diseases (134)
Real estate (2309)
Recruiting (17)
Regulatory (8334)
Reports (18)
Research institute (771)
Resumes & cover letters (83)
Rett syndrome (4)
RNA editing (1)
RSV (5)
Schizophrenia (24)
Series A (37)
Series B (29)
Sickle cell disease (27)
Special edition (5)
Spinal muscular atrophy (40)
Sponsored (7)
Startups (1250)
Stomach cancer (2)
Supply chain (16)
Tariffs (10)
The Weekly (12)
Vaccines (139)
Venture capitalists (7)
Weight loss (55)
Women's health (8)
Worklife (3)
Date
Today (16)
Last 7 days (475)
Last 30 days (1250)
Last 365 days (14348)
2025 (4721)
2024 (15988)
2023 (18704)
2022 (24880)
2021 (26325)
2020 (25096)
2019 (21033)
2018 (15928)
2017 (14009)
2016 (13465)
2015 (16920)
2014 (13187)
2013 (10585)
2012 (11333)
2011 (12230)
2010 (11933)
Location
Africa (270)
Alabama (35)
Alaska (5)
Arizona (81)
Arkansas (5)
Asia (15592)
Australia (2398)
California (2753)
Canada (920)
China (178)
Colorado (116)
Connecticut (140)
Delaware (63)
Europe (33899)
Florida (441)
Georgia (71)
Idaho (27)
Illinois (217)
India (10)
Indiana (120)
Iowa (3)
Japan (99)
Kansas (42)
Kentucky (16)
Louisiana (7)
Maine (44)
Maryland (393)
Massachusetts (2117)
Michigan (119)
Minnesota (185)
Mississippi (2)
Missouri (44)
Montana (26)
Nebraska (13)
Nevada (39)
New Hampshire (23)
New Jersey (869)
New Mexico (10)
New York (678)
North Carolina (492)
North Dakota (5)
Northern California (1280)
Ohio (89)
Oklahoma (6)
Oregon (8)
Pennsylvania (513)
Puerto Rico (1)
Rhode Island (14)
South America (467)
South Carolina (14)
Southern California (1021)
Tennessee (56)
Texas (336)
United States (10340)
Utah (79)
Virginia (70)
Washington D.C. (31)
Washington State (241)
West Virginia (2)
Wisconsin (30)
314,194 Results for "american cryostem corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
American CryoStem Announces the Addition of Agustin Legido, MD, PhD, MBA to Its Advisory Board
American CryoStem Corporation (OTC Pink: CRYO), a clinical-stage therapeutics company with a proprietary end-to-end core biotechnology platform of tissue-based cellular technologies powering its clinical pipeline, announced today that Agustin Legido, MD, PhD, MBA has joined its Scientific and Medical Advisory Board.
December 22, 2022
·
4 min read
Press Releases
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
March 5, 2025
·
9 min read
Drug Development
American CryoStem Announces FDA Approval of IND to Commence Phase I Clinical Trial for Long COVID/Post-Acute Sequelae of SARS-CoV-2 (PASC)
American CryoStem Corporation (OTC Pink: CRYO), a clinical-stage therapeutics company with a proprietary end-to-end core biotechnology platform of tissue-based cellular technologies that powers its clinical pipeline, announced today that it has received U.S. Food and Drug Administration (FDA) approval to proceed with a Phase I Clinical Trial for the treatment of Long COVID/PASC.
January 6, 2023
·
4 min read
Press Releases
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
April 2, 2025
·
4 min read
Press Releases
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
April 21, 2025
·
1 min read
Press Releases
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
May 2, 2025
·
1 min read
Pharm Country
American CryoStem Completes Clinical Protocol Design for Long COVID Study
American CryoStem Corporation, a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies announced completion of its Phase I clinical protocol design for the treatment of Long COVID.
November 30, 2021
·
3 min read
Press Releases
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
March 5, 2025
·
12 min read
Tariffs
Biotech’s Next Phase Will Be All-American: Pitchbook
With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.
April 17, 2025
·
2 min read
·
Annalee Armstrong
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American College of Cardiology (ACC.24) at the Georgia World Congress Center in Atlanta, GA, April 6 – 8, 2024.
April 1, 2024
·
3 min read
1 of 31,420
Next
